Merrimack Pharmaceuticals, Inc.
MACK
$0.02
Change (1 day)
$15.89
Year High
$11.53
Year Low
Categories
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
P/S ratio for Merrimack Pharmaceuticals, Inc. (MACK)
P/S ratio as of 2023: 0.00
According to Merrimack Pharmaceuticals, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.00. At the end of 2022 the company had a P/S ratio of 0.00.
P/S ratio history for Merrimack Pharmaceuticals, Inc. from 2009 to 2023
P/S ratio at the end of each year
| Year | P/S ratio |
|---|---|
| 2023 | 0.00 |
| 2022 | 0.00 |
| 2021 | 0.00 |
| 2020 | 0.00 |
| 2019 | 0.00 |
| 2018 | 0.00 |
| 2017 | 0.00 |
| 2016 | 2.79 |
| 2015 | 7.75 |
| 2014 | 9.03 |
| 2013 | 8.68 |
| 2012 | 7.13 |
| 2011 | 12.83 |
| 2010 | 2.65 |
| 2009 | 25.09 |